Challenges & Solutions - CBD and Hemp
CBD/Hemp is a very crowded category with lots of competition with tremendous potential. Buyers are overwhelmed with brands seeking distribution. Consumers are confused on what the product does or does not do. How do you communicate to retailers and consumers how your brand is different and deserves their attention? How does a brand do all of this and run your day to day business profitably?
The Road to Retail session will provide specific details and actions for your consideration that will help you address the challenges confronting your business.
The Road to Retail team has been at the forefront of the hemp movement and is a leader in the natural products industry. Our teams at Informa/New Hope Network have called on them to support our educational programming as expert presenters and industry advisors.
The Road to Retail team were key partners in helping us launch mood33. They provided a ton of insight and knowledge to help our company navigate this difficult landscape, and ensure we were in full compliance. With their support we were able to have a smooth national launch, and fortunately saved thousands of dollars on compliance and testing.
I have been in the natural products industry for about 9 years. When I decided to add a CBD line to my healthy candy company it was the Road to Retail team that I called first. I can rely on them to have the latest, most up-to-date information and their personal and business ethics are always in the right place.
Tracey is a 30- year veteran of the CPG industry rich with experience in both sales and marketing. Held several sales positions at blue chip companies where he drove specific programs increasing both market share and sales with large retailers in all classes of trade. For more than a decade he has owned and operated a sales and trade marketing consulting firm providing sales leadership with some the most notable CPG companies and emerging brands.
Bruce has been in commercial operations functions within CPG firms for the majority of his 30 year career. He has served in executive leadership positions in marketing, sales, business development, new product development, logistics, store brand, and brand acquisition & divestiture. He was part of the executive team that led the successful sale of Fleet Laboratories to private equity in 2015.
Jourdan is a sales executive in the CPG industry. He co-founded the brand Evo Hemp in 2012, to establishing a supply chain of USA grown hemp and develop innovative consumer products. These products can now be found in over 3,000 retail stores nationwide including HEB, Whole Foods Market, Publix, Fresh Market, Kroger... Jourdan was also recognized by Forbes magazine as a 30 under 30 member in the Food and Drink category.
Ari is a marketing executive in the CPG industry. He co-founded the brand Evo Hemp in 2012, to establishing a supply chain of USA grown hemp and develop innovative consumer products. These products can now be found in over 3,000 retail stores nationwide including HEB, Whole Foods Market, Publix, Fresh Market, Kroger... Jourdan was also recognized by Forbes magazine as a 30 under 30 member in the Food and Drink category.
In his current role as Senior Director of Strategy at Pathfinders Advertising, Garrett Gingerich builds client brands by connecting them to their audiences at key moments in the customer journey through integrated marketing, design, and digital experiences. His portfolio of work includes brands such as Visit South Bend Mishawaka, City of South Bend, Fifth Third Bank, PayPal, Maytag, First Student, and Boxed Water.
Vicky has built an impressive marketing career over the past 30 years by developing expertise in the CPG industry. She’s helped shape major brands within Abbott Labs, Bank of America, Whirlpool Corporation, Merck, Novartis, Mead Johnson, and Welch’s. Vicky has helped launched cutting-edge medical products for Stryker and Exsurco Medical — and has helped dozens of OTC/HBA brands find success in the marketplace.
Minor has been responsible for direct investment activities in both the Phoenix Therapeutics, Inc. joint venture with The Carlyle Group, and Covis Pharma S.à.r.l (“Covis”). Minor also served on the U.S. Board of Covis and executed investments in AMRI, WellDyne, Novitium, iNova, Cadence RX as well as various fund investments. Minor also serves on the Board on BPSC’s investment in Pharmaceutical Associates